Overview

TGRX-678 Phase I Oral Pharmacokinetic Study

Status:
COMPLETED
Trial end date:
2025-02-20
Target enrollment:
Participant gender:
Summary
A study evaluating the effects of food intake on the pharmacokinetic (PK) profiles of TGRX-678
Phase:
PHASE1
Details
Lead Sponsor:
Shenzhen TargetRx, Inc.
Collaborator:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School